Overview Liposomal Bupivacaine in Rotator Cuff Repair Status: Recruiting Trial end date: 2022-12-01 Target enrollment: Participant gender: Summary To assess the efficacy of interscalene liposomal bupivacaine in controlling postoperative pain scores, oral morphine equivalents and sleep quality after arthroscopic rotator cuff repair surgery as compared to interscalene catheter. Phase: Phase 4 Details Lead Sponsor: University of Alabama at BirminghamCollaborator: Pacira Pharmaceuticals, IncTreatments: BupivacaineRopivacaineSodium Channel Blockers